ELVN
Enliven Therapeutics, Inc.
Company overview
- Market capitalization
- $3.37B
- Employees
- 61
- Latest publication
- 2026-09-29
About Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 316,000USD | 0USD | 0USD |
| Cost Of Revenue | 14,000USD | 46,000USD | — | 81,000USD | 74,000USD | 158,000USD | 80,000USD | 79,000USD |
| Gross Profit | -14,000USD | -46,000USD | — | -81,000USD | -74,000USD | 158,000USD | -80,000USD | -79,000USD |
| Research Development | 20,687,000USD | 21,245,000USD | 18,225,000USD | 21,491,000USD | 24,895,000USD | 20,724,000USD | 21,258,000USD | 18,826,000USD |
| Selling General Administrative | 7,136,000USD | 13,040,000USD | 6,871,000USD | 7,093,000USD | 6,798,000USD | 6,172,000USD | 5,810,000USD | 5,777,000USD |
| Total Operating Expenses | 27,823,000USD | 34,239,000USD | 25,096,000USD | 28,584,000USD | 31,693,000USD | 26,896,000USD | 27,068,000USD | 24,603,000USD |
| Operating Income | -27,823,000USD | -34,285,000USD | -25,096,000USD | -28,584,000USD | -31,693,000USD | -26,896,000USD | -27,068,000USD | -24,603,000USD |
| Interest Income | 4,196,000USD | 4,618,000USD | 4,948,000USD | 3,251,000USD | 3,196,000USD | 3,716,000USD | 3,839,000USD | 4,086,000USD |
| Net Interest Income | 4,196,000USD | 4,618,000USD | 4,948,000USD | 3,251,000USD | 3,196,000USD | 3,716,000USD | 3,839,000USD | 4,086,000USD |
| Income Before Tax | -23,627,000USD | -29,667,000USD | -20,148,000USD | -25,335,000USD | -28,544,000USD | -23,180,000USD | -23,156,000USD | -19,718,000USD |
| Net Income | -23,627,000USD | -29,667,000USD | -20,148,000USD | -25,335,000USD | -28,544,000USD | -23,180,000USD | -23,156,000USD | -19,950,000USD |
| Net Income From Continuing Ops | -23,627,000USD | -29,667,000USD | -20,148,000USD | -25,335,000USD | -28,544,000USD | -23,180,000USD | -23,156,000USD | -19,950,000USD |
| Ebit | -27,837,000USD | -34,285,000USD | -20,148,000USD | -28,584,000USD | -31,693,000USD | -26,896,000USD | -27,068,000USD | -24,603,000USD |
| Ebitda | -27,823,000USD | -34,239,000USD | -20,086,000USD | -28,503,000USD | -31,619,000USD | -26,816,000USD | -26,988,000USD | -24,525,000USD |
| Depreciation And Amortization | 14,000USD | 46,000USD | 62,000USD | 81,000USD | 74,000USD | 80,000USD | 80,000USD | 78,000USD |
| Reconciled Depreciation | 14,000USD | 46,000USD | 62,000USD | 81,000USD | 74,000USD | 80,000USD | 80,000USD | 78,000USD |
| Total Other Income Expense Net | 4,196,000USD | 4,618,000USD | 4,948,000USD | 3,249,000USD | 3,149,000USD | 3,716,000USD | 3,912,000USD | 4,885,000USD |
| Tax Provision | — | 0USD | 0USD | 0USD | — | 0USD | 0USD | 232,000USD |
| Income Tax Expense | — | — | — | — | — | -500,000USD | — | 232,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — | — |
| Cost Of Revenue | 263,000USD | 317,000USD | 297,000USD | 622,000USD | 99,000USD | 97,000USD | 33,000USD | — |
| Gross Profit | -263,000USD | -317,000USD | -297,000USD | -622,000USD | -99,000USD | -97,000USD | -33,000USD | — |
| Research Development | 85,856,000USD | 80,778,000USD | 64,574,000USD | 31,022,000USD | 20,474,000USD | 8,240,000USD | 19,009,000USD | 8,239,000USD |
| Selling General Administrative | 33,802,000USD | 23,776,000USD | 18,955,000USD | 7,769,000USD | 4,288,000USD | 1,078,000USD | 5,107,000USD | 2,438,000USD |
| Total Operating Expenses | 119,395,000USD | 104,554,000USD | 83,529,000USD | 38,791,000USD | 24,762,000USD | 9,318,000USD | 24,083,000USD | 10,677,000USD |
| Operating Income | -119,658,000USD | -104,554,000USD | -83,529,000USD | -38,791,000USD | -24,762,000USD | -9,318,000USD | -24,116,000USD | -10,677,000USD |
| Interest Income | 16,013,000USD | 14,891,000USD | 11,967,000USD | 1,129,000USD | 22,000USD | 31,000USD | — | — |
| Net Interest Income | 16,013,000USD | 14,891,000USD | 11,967,000USD | 1,129,000USD | 22,000USD | 31,000USD | — | — |
| Income Before Tax | -103,694,000USD | -88,792,000USD | -71,584,000USD | -37,662,000USD | -24,740,000USD | -18,966,000USD | -23,463,000USD | -11,337,000USD |
| Tax Provision | 0USD | 232,000USD | 0USD | — | — | — | — | — |
| Net Income | -103,694,000USD | -89,024,000USD | -71,584,000USD | -37,662,000USD | -24,740,000USD | -18,966,000USD | -23,463,000USD | -11,337,000USD |
| Net Income From Continuing Ops | -103,694,000USD | -89,024,000USD | -71,584,000USD | -37,662,000USD | -24,740,000USD | -18,966,000USD | — | — |
| Ebit | -119,658,000USD | -104,554,000USD | -83,529,000USD | -38,791,000USD | -24,762,000USD | -9,318,000USD | -23,463,000USD | -10,677,000USD |
| Ebitda | -119,395,000USD | -104,237,000USD | -83,232,000USD | -38,576,000USD | -24,647,000USD | -9,273,000USD | -23,430,000USD | -11,337,000USD |
| Depreciation And Amortization | 263,000USD | 317,000USD | 297,000USD | 215,000USD | 115,000USD | 45,000USD | 33,000USD | -660,000USD |
| Reconciled Depreciation | 263,000USD | 317,000USD | 297,000USD | 215,000USD | 115,000USD | 45,000USD | — | — |
| Total Other Income Expense Net | 15,964,000USD | 15,762,000USD | 11,945,000USD | 1,129,000USD | 22,000USD | -9,648,000USD | 653,000USD | -660,000USD |
| Income Tax Expense | — | 232,000USD | 1,300,000USD | 88,000USD | -22,000USD | -31,000USD | 653,000USD | -821,000USD |
| Interest Expense | — | — | — | 1,217,000USD | 93,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | — | -24,740,000USD | -18,966,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | 33,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 910,223,000USD | 464,852,000USD | 476,168,000USD | 490,875,000USD | 503,887,000USD | 302,570,000USD | 325,760,000USD | 305,430,000USD |
| Cash And Equivalents | 135,505,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 895,155,000USD | 452,401,000USD | 462,621,000USD | 477,565,000USD | 490,503,000USD | 289,555,000USD | 313,440,000USD | 291,834,000USD |
| Short Term Investments | 759,650,000USD | 320,217,000USD | 363,725,000USD | 375,833,000USD | 371,066,000USD | 187,850,000USD | 189,323,000USD | 191,213,000USD |
| Total Current Assets | 907,339,000USD | 463,137,000USD | 474,878,000USD | 482,683,000USD | 495,622,000USD | 294,318,000USD | 318,127,000USD | 296,997,000USD |
| Other Current Assets | 12,184,000USD | 10,736,000USD | 12,257,000USD | 5,118,000USD | 5,119,000USD | 4,763,000USD | 4,687,000USD | 5,163,000USD |
| Other Non Current Assets | 1,242,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 15,074,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 14,161,000USD | 11,487,000USD | 16,568,000USD | 14,650,000USD | 15,211,000USD | 13,972,000USD | 15,915,000USD | 17,027,000USD |
| Other Non Current Liabilities | 913,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 895,149,000USD | 453,365,000USD | 459,600,000USD | 476,122,000USD | 488,472,000USD | 288,296,000USD | 309,845,000USD | 288,403,000USD |
| Total Equity Including Noncontrolling Interest | 895,149,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,642,000USD | 310,000USD | 417,000USD | 874,000USD | 1,026,000USD | 1,055,000USD | 458,000USD | 630,000USD |
| Accounts Payable | 371,000USD | 1,640,000USD | 2,159,000USD | 1,429,000USD | 2,351,000USD | 1,562,000USD | 1,342,000USD | 1,019,000USD |
| Common Stock | 73,000USD | 61,000USD | 59,000USD | 59,000USD | 59,000USD | 49,000USD | 49,000USD | 47,000USD |
| Retained Earnings | -403,278,000USD | -370,793,000USD | -347,166,000USD | -317,499,000USD | -297,351,000USD | -272,016,000USD | -243,472,000USD | -220,292,000USD |
| Accumulated Other Comprehensive Income | -1,905,000USD | -382,000USD | 334,000USD | 221,000USD | -177,000USD | -16,000USD | 55,000USD | 242,000USD |
| Total Liab | — | 11,487,000USD | 16,675,999USD | 14,753,000USD | 15,415,000USD | 14,274,000USD | 15,915,000USD | 17,027,000USD |
| Other Current Liab | — | 9,545,000USD | 14,010,000USD | 12,834,000USD | 12,484,000USD | 12,045,000USD | 14,573,000USD | 15,923,000USD |
| Capital Stock | — | 61,000USD | 59,000USD | 59,000USD | 59,000USD | 49,000USD | 49,000USD | 47,000USD |
| Cash | — | 132,184,000USD | 98,896,000USD | 101,732,000USD | 119,437,000USD | 101,705,000USD | 124,117,000USD | 100,621,000USD |
| Net Debt | — | -131,882,000USD | -98,497,000USD | -101,345,000USD | -118,857,000USD | -101,340,000USD | -124,117,000USD | -100,536,000USD |
| Short Term Debt | — | 302,000USD | 399,000USD | 387,000USD | 376,000USD | 365,000USD | — | 85,000USD |
| Short Long Term Debt Total | — | 302,000USD | 399,000USD | 387,000USD | 580,000USD | 365,000USD | — | 85,000USD |
| Property Plant Equipment Gross | — | 553,000USD | 646,000USD | 2,010,000USD | 2,100,000USD | 2,048,000USD | 1,377,000USD | 1,538,000USD |
| Common Stock Shares Outstanding | — | 62,799,326shares | 56,664,226shares | 62,093,795shares | 52,105,052shares | 50,051,000shares | 49,858,000shares | 48,267,000shares |
| Non Current Assets Total | — | 1,715,000USD | 1,290,000USD | 8,192,000USD | 8,265,000USD | 8,252,000USD | 7,633,000USD | 8,433,000USD |
| Non Current Liabilities Total | — | 0USD | 107,999USD | 103,000USD | 204,000USD | 302,000USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 1,405,000USD | 873,000USD | 7,318,000USD | 7,239,000USD | 7,197,000USD | 7,175,000USD | 7,803,000USD |
| Net Working Capital | — | 451,650,000USD | 458,310,000USD | 468,033,000USD | 480,411,000USD | 280,346,000USD | 302,212,000USD | 279,970,000USD |
| Unclassified Equity | — | 824,418,000USD | 806,314,000USD | 793,282,000USD | 785,882,000USD | 560,230,000USD | 553,164,000USD | 508,359,000USD |
| Non Current Liabilities Other | — | — | — | 103,000USD | — | 302,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 476,168,000USD | 325,760,000USD | 271,867,000USD | 83,298,000USD | 113,329,000USD | 90,842,000USD | 33,298,000USD | 7,705,000USD |
| Other Current Assets | 12,257,000USD | 4,687,000USD | 13,003,000USD | 2,217,000USD | 646,000USD | 2,183,000USD | 1,717,000USD | 323,000USD |
| Total Liab | 16,675,999USD | 15,915,000USD | 25,961,000USD | 160,123,000USD | 6,467,000USD | 6,407,000USD | 4,382,000USD | 1,832,000USD |
| Total Stockholder Equity | 459,600,000USD | 309,845,000USD | 245,906,000USD | -76,825,000USD | 106,862,000USD | 84,435,000USD | -48,848,000USD | -26,316,000USD |
| Other Current Liab | 14,010,000USD | 14,573,000USD | 25,027,000USD | 447,000USD | 3,073,000USD | 4,276,000USD | 2,540,000USD | 924,000USD |
| Common Stock | 59,000USD | 49,000USD | 41,000USD | 1,000USD | 1,000USD | 18,000USD | 4,000USD | 4,000USD |
| Capital Stock | 59,000USD | 49,000USD | 41,000USD | 1,000USD | 1,000USD | 1,000USD | — | — |
| Retained Earnings | -347,166,000USD | -243,472,000USD | -154,448,000USD | -82,864,000USD | -45,202,000USD | -96,113,000USD | -54,753,000USD | -31,290,000USD |
| Cash | 98,896,000USD | 124,117,000USD | 100,141,000USD | 75,536,000USD | 110,024,000USD | 47,698,000USD | 4,936,000USD | 7,382,000USD |
| Cash And Short Term Investments | 462,621,000USD | 313,440,000USD | 253,148,000USD | 75,536,000USD | 110,024,000USD | 88,222,000USD | 28,907,000USD | 7,382,000USD |
| Total Current Assets | 474,878,000USD | 318,127,000USD | 266,151,000USD | 77,753,000USD | 110,670,000USD | 90,405,000USD | 30,624,000USD | 7,705,000USD |
| Total Current Liabilities | 16,568,000USD | 15,915,000USD | 25,894,000USD | 9,715,000USD | 5,753,000USD | 6,247,000USD | 4,198,000USD | 1,832,000USD |
| Net Debt | -98,497,000USD | -124,117,000USD | -99,806,000USD | -75,213,000USD | -109,865,000USD | -47,698,000USD | -4,936,000USD | -7,382,000USD |
| Short Term Debt | 399,000USD | — | 335,000USD | 323,000USD | 159,000USD | 105,000USD | — | — |
| Short Long Term Debt Total | 399,000USD | — | 335,000USD | 323,000USD | 159,000USD | 105,000USD | — | — |
| Short Term Investments | 363,725,000USD | 189,323,000USD | 153,007,000USD | 0USD | 41,969,000USD | 40,524,000USD | 23,971,000USD | — |
| Accounts Payable | 2,159,000USD | 1,342,000USD | 532,000USD | 3,438,000USD | 2,521,000USD | 1,971,000USD | 1,658,000USD | 908,000USD |
| Property Plant Equipment Net | 417,000USD | 458,000USD | 1,062,000USD | 1,516,000USD | 954,000USD | 349,000USD | 442,000USD | — |
| Property Plant Equipment Gross | 646,000USD | 1,377,000USD | 1,733,000USD | 1,890,000USD | 1,114,000USD | 461,000USD | — | — |
| Accumulated Other Comprehensive Income | 334,000USD | 55,000USD | 141,000USD | -149,749USD | -16,000USD | 4,000USD | 32,000USD | — |
| Common Stock Shares Outstanding | 56,664,226shares | 47,073,000shares | 35,546,000shares | 6,249,000shares | 7,815,000shares | 4,390,500shares | 4,320,000shares | 4,320,000shares |
| Non Current Assets Total | 1,290,000USD | 7,633,000USD | 5,716,000USD | 5,545,000USD | 2,659,000USD | 437,000USD | 2,674,000USD | — |
| Non Current Liabilities Total | 107,999USD | 0USD | 67,000USD | 150,408,000USD | 714,000USD | 160,000USD | 184,000USD | 32,189,000USD |
| Non Currrent Assets Other | 873,000USD | 7,175,000USD | 4,654,000USD | 3,975,000USD | 1,705,000USD | 88,000USD | 2,144,000USD | — |
| Net Working Capital | 458,310,000USD | 302,212,000USD | 240,257,000USD | 68,038,000USD | 104,917,000USD | 129,109,000USD | — | — |
| Unclassified Equity | 806,314,000USD | 553,164,000USD | 400,131,000USD | 6,186,749USD | 152,078,000USD | 180,525,000USD | 5,869,000USD | 4,970,000USD |
| Non Current Liabilities Other | — | — | 67,000USD | 659,000USD | 714,000USD | 80,000USD | — | — |
| Current Deferred Revenue | — | — | — | 5,507,000USD | 2,703,000USD | 429,000USD | — | — |
| Unclassified Non Current Liabilities | — | — | — | 149,749,000USD | -1,651,000USD | — | — | 32,189,000USD |
| Deferred Long Term Liab | — | — | — | — | 1,651,000USD | — | — | — |
| Other Assets | — | — | — | — | 0USD | — | — | — |
| Net Tangible Assets | — | — | — | — | -42,887,000USD | -20,304,000USD | — | — |
| Unclassified Current Assets | — | — | — | — | -41,969,000USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | -2,703,000USD | — | — | — |
| Other Liab | — | — | — | — | — | 80,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -23,627,000USD | -29,667,000USD | -20,148,000USD | -25,335,000USD | -28,544,000USD | -23,180,000USD | -23,156,000USD | -19,950,000USD |
| Depreciation | 280,000USD | 101,000USD | 62,000USD | 154,000USD | 74,000USD | 80,000USD | 80,000USD | 78,000USD |
| Stock Based Compensation | 7,397,000USD | 12,311,000USD | 7,185,000USD | 7,724,000USD | 6,799,000USD | 5,339,000USD | 5,176,000USD | 5,144,000USD |
| Other Non Cash Items | 93,000USD | 198,000USD | -221,000USD | 87,000USD | 40,000USD | 1,068,000USD | 719,000USD | -1,323,000USD |
| Change In Working Capital | -3,434,000USD | 1,219,000USD | -157,000USD | 313,000USD | -2,496,000USD | -510,000USD | 4,988,000USD | -4,384,000USD |
| Total Cash From Operating Activities | -19,291,000USD | -15,838,000USD | -13,279,000USD | -17,057,000USD | -24,127,000USD | -17,203,000USD | -12,193,000USD | -20,435,000USD |
| Capital Expenditures | 0USD | 0USD | -1,000USD | -139,000USD | -20,000USD | 0USD | -22,000USD | -2,000USD |
| Free Cash Flow | -19,291,000USD | -15,838,000USD | -13,278,000USD | -17,196,000USD | -24,147,000USD | -17,203,000USD | -12,215,000USD | -20,437,000USD |
| Investments | 42,526,000USD | 12,166,000USD | -4,058,000USD | -183,589,000USD | 1,427,000USD | 727,000USD | 14,826,000USD | -33,665,000USD |
| Total Cashflows From Investing Activities | 42,526,000USD | 12,379,000USD | -4,058,000USD | -183,589,000USD | 1,427,000USD | 727,000USD | 14,826,000USD | -33,665,000USD |
| Total Cash From Financing Activities | 10,053,000USD | 623,000USD | -368,000USD | 218,378,000USD | 234,000USD | 39,972,000USD | 1,117,000USD | 1,806,000USD |
| Change In Cash | 33,288,000USD | -2,836,000USD | -17,705,000USD | 17,732,000USD | -22,466,000USD | 23,496,000USD | 3,750,000USD | -52,294,000USD |
| Begin Period Cash Flow | 98,896,000USD | 101,732,000USD | 119,437,000USD | 101,705,000USD | 124,171,000USD | 100,675,000USD | 96,925,000USD | 149,219,000USD |
| End Period Cash Flow | 132,184,000USD | 98,896,000USD | 101,732,000USD | 119,437,000USD | 101,705,000USD | 124,171,000USD | 100,675,000USD | 96,925,000USD |
| Other Cashflows From Financing Activities | 10,053,000USD | 623,000USD | -368,000USD | 218,378,000USD | 234,000USD | 90,479,000USD | 1,117,000USD | 1,806,000USD |
| Sale Purchase Of Stock | — | 620,000USD | — | — | — | — | 320,000USD | — |
| Issuance Of Capital Stock | — | 0USD | -458,000USD | 216,627,000USD | 0USD | -50,507,000USD | 0USD | -305,000USD |
| Other Cashflows From Investing Activities | — | 213,000USD | — | — | — | — | 52,401,000USD | 10,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | -216,627,000USD | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | -52,379,000USD | -9,998,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -103,694,000USD | -89,024,000USD | -71,584,000USD | -37,662,000USD | -24,740,000USD | -18,966,000USD | -23,463,000USD | -11,337,000USD |
| Depreciation | 263,000USD | 317,000USD | 297,000USD | 215,000USD | 115,000USD | 45,000USD | 33,000USD | — |
| Stock Based Compensation | 34,019,000USD | 20,174,000USD | 12,914,000USD | 3,191,000USD | 1,924,000USD | 130,000USD | 899,000USD | 555,000USD |
| Other Non Cash Items | 232,000USD | -118,000USD | -4,297,000USD | 1,741,000USD | 3,809,000USD | 9,679,000USD | 196,000USD | 848,000USD |
| Change In Working Capital | -1,121,000USD | -4,541,000USD | 1,401,000USD | 438,000USD | 3,567,000USD | 583,000USD | 673,000USD | 1,235,000USD |
| Total Cash From Operating Activities | -70,301,000USD | -73,192,000USD | -61,269,000USD | -32,077,000USD | -19,134,000USD | -8,529,000USD | -21,877,000USD | -8,777,000USD |
| Capital Expenditures | -158,000USD | -44,000USD | -149,000USD | -612,000USD | -191,000USD | -461,000USD | -140,000USD | 0USD |
| Free Cash Flow | -70,459,000USD | -73,236,000USD | -61,418,000USD | -32,689,000USD | -19,325,000USD | -8,990,000USD | -22,017,000USD | -8,777,000USD |
| Investments | -173,896,000USD | -35,997,000USD | -148,412,000USD | -612,000USD | -191,000USD | -461,000USD | — | — |
| Total Cashflows From Investing Activities | -173,841,000USD | -35,997,000USD | -148,412,000USD | -612,000USD | -191,000USD | -461,000USD | -24,060,000USD | — |
| Total Cash From Financing Activities | 218,867,000USD | 133,165,000USD | 234,286,000USD | -1,799,000USD | -1,016,000USD | 130,513,000USD | 43,579,000USD | 6,488,000USD |
| Sale Purchase Of Stock | 620,000USD | — | — | 1,000USD | -226,000USD | — | — | — |
| Issuance Of Capital Stock | 216,169,000USD | 39,188,000USD | 0USD | 591,000USD | 690,000USD | 130,513,000USD | — | — |
| Change In Cash | -25,275,000USD | 23,976,000USD | 24,605,000USD | -34,488,000USD | -20,341,000USD | 121,523,000USD | -2,446,000USD | -2,289,000USD |
| Begin Period Cash Flow | 124,171,000USD | 100,195,000USD | 75,590,000USD | 110,078,000USD | 130,419,000USD | 8,896,000USD | 7,382,000USD | 9,671,000USD |
| End Period Cash Flow | 98,896,000USD | 124,171,000USD | 100,195,000USD | 75,590,000USD | 110,078,000USD | 130,419,000USD | 4,936,000USD | 7,382,000USD |
| Other Cashflows From Investing Activities | 213,000USD | 873,000USD | — | -41,878,000USD | 1,620,000USD | 16,703,000USD | — | — |
| Other Cashflows From Financing Activities | 218,867,000USD | 93,977,000USD | 73,085,000USD | -566,000USD | -1,242,000USD | 33,632,000USD | -24,060,000USD | 6,488,000USD |
| Unclassified Financing Cash Flow | — | — | 161,201,000USD | -1,234,000USD | — | -33,632,000USD | 67,639,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | 42,490,000USD | -1,429,000USD | -16,242,000USD | -23,920,000USD | — |
| Change To Liabilities | — | — | — | — | 1,734,000USD | 291,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | -3,809,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.